TREVICTA PALIPERIDONE 350MG INJECTION

Trevicta (generic name: paliperidone palmitate) is an injectable antipsychotic medication primarily used for the treatment of schizophrenia in adults. It is a long-acting formulation of paliperidone, which is an active metabolite of risperidone. Trevicta is administered as an intramuscular injection, typically every three months, providing a convenient option for patients who may have difficulty adhering to daily oral medication regimens.

The drug works by modulating the effects of neurotransmitters in the brain, particularly dopamine and serotonin, which are implicated in the symptoms of schizophrenia. Trevicta helps to reduce the risk of relapse and manage symptoms such as hallucinations, delusions, and disorganized thinking. Additionally, it may be used in some cases for the treatment of schizoaffective disorder. Overall, Trevicta offers a long-term treatment solution for individuals with chronic mental health conditions.